Investor Relations

Welcome to the Investor Relations section of the Cynapsus Therapeutics website. This area is dedicated to keeping shareholders and potential investors up to date with detailed and accurate information.

Investor Alerts

To receive email alerts of future company announcments contact us at [email protected]

Link to EDGAR

Cynapsus' public securities documents and information can be found on EDGAR at

Link to SEDAR

Cynapsus' public securities documents and information can be found on SEDAR at


2015 Calendar

Key Dates

Cowen & Co. 36th Annual Health Care Conference
March 7, 2022
Boston Marriott Copley Place Hotel at
1:20 p.m. EST in the Vineyard Conference Room on the 4th Floor.

Video Webcast

YE 2015 Results
March 9, 2022

Annual General Meeting of the Shareholders
May 10, 2022

Q1 2016 Results
May 10, 206

Q2 2016 Results
August 10, 2021

Q3 2016 Results
November 9, 2021

2016 Financial Year End
December 31, 2021


Analyst Coverage

Bank of America Merrill Lynch, Initiation of Coverage (Jul 2015) – Sumant S. Kulkarni ([email protected])

Nomura, Initiation of Coverage (Jul 2015) – Do Kim ([email protected])

Noble Financial, Initiation of Coverage (Jul 2013) - Nathan Cali ([email protected])

M Partners, Initiation of Coverage (Jan 2014) - Daniel Pearlstein ([email protected])

Rx Securities, Initiation of Coverage (Nov 2015) – Dr. Samir Devani ([email protected])

Cynapsus is followed by the research analysts listed. Please note that any opinions, estimates, or forecasts regarding Cynapsus’ performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Cynapsus or its management. Cynapsus does not, by its reference or distribution, imply its endorsement of, or concurrence with, such information, conclusions, or recommendations.

Cynapsus does not provide analyst reports to persons outside of the company. Please contact the research analyst directly to obtain a report.


PFIC Statements

Click to download the 2015 PFIC Annual Information Statement

Click to download the 2014 PFIC Annual Information Statement 

Horizonatal Rule
About CynapsusLine SeperationAPL-130277 ProductLine SeperationParkinson's DiseaseLine SeperationInvestor RelationsLine SeperationContact & LegalLine Seperation

Copyright 2016, Cynapsus Therapeutics Inc.
All rights reserved.

Traded on